Engineered “mini livers” could be injected as an alternative to transplantation
Researchers develop injectable mini livers to treat chronic disease without traditional organ transplantation.
A technology developed by Professor Sangeeta Bhatia, SM ’93, PhD ’97, and colleagues could offer new hope to the thousands of Americans with chronic liver disease who are waiting for an organ transplant or not strong enough to tolerate one. The liver is involved in regulating blo...
MIT Technology Review
Source

Generated insight by OnAirToday AI
This breakthrough leverages regenerative medicine to bypass the severe organ shortage crisis and the risks associated with major transplant surgery. By enabling localized liver function through injection, this technology could fundamentally transform how we treat end-stage organ failure.
Get the day's AI news in one short email. Free.
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.